ESC Premium Access

ABSORB Japan: 2-year clinical results from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs. metallic drug-eluting stent in de novo native coronary artery lesions

Congress Presentation

About the speaker

Professor Takeshi Kimura

Hirakata Kohsai Hospital, Hirakata (Japan)
5 presentations
1 follower

5 more presentations in this session

5-year outcomes after implantation of biodegradable polymer-coated biolimus-eluting stents versus durable polymer-coated sirolimus-eluting stents in unselected patients

Speaker: Mr E. Christiansen (Aarhus, DK)


A life-time perspective on the effects of an early invasive compared with a non-invasive treatment strategy in patients with non-ST-elevation acute coronary syndrome - the FRISC II 15 years follow-up

Speaker: Professor L. Wallentin (Uppsala, SE)


10-year follow-up of clinical outcomes in a randomized trial comparing routine invasive versus selective invasive management in patients with non ST-segment elevation acute coronary syndrome.

Speaker: Professor R. De Winter (Amsterdam, NL)


Comparative Efficacy of Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention in Diabetic Patients with Multivessel Coronary Artery Disease With or Without Renal Dysfunction

Speaker: Doctor U. Baber (New York, US)


The effect of CABG by age in patients with heart failure: 10 year follow data from the STICHES study

Speaker: Professor E. Velazquez (New Haven, US)


Access the full session

Clinical Trial Update Coronary artery disease

Speakers: Professor T. Kimura, Mr E. Christiansen, Professor L. Wallentin, Professor R. De Winter, Doctor U. Baber...

About the event


ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by